Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion type Assertion NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_head.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion description "[Ten years after diagnosis, 35% of CD and 51% of CRD had a bull's eye maculopathy; 70% of CRD showed absolute peripheral visual field defects and 37% of CD developed rod involvement on ERG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_provenance.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion evidence source_evidence_literature NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_provenance.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion SIO_000772 22264887 NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_provenance.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion wasDerivedFrom befree-20140225 NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_provenance.
- NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_assertion wasGeneratedBy ECO_0000203 NP713710.RAClaa40JNIEiCgX9OXJaBiiWn38nSaHG18XNf0MydlWc130_provenance.